Advancements in Bladder Cancer: The Future is Now – Part Two
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Advancements in Bladder Cancer: The Future is Now – Part Two
-
Narrated by:
-
Written by:
About this listen
In part two of a two-part interview, WInnovations host Dr. Kyle Richards is joined by Dr. Elizabeth Koehne, assistant professor and urologic oncologist at the University of Wisconsin Department of Urology, and Dr. Sam Chang, professor and chief of urologic oncology at Vanderbilt University. The conversation continues with a deeper dive into emerging treatments for non–muscle invasive bladder cancer, with a particular focus on the growing role of biomarkers in guiding care and identifying the right therapy for the right patient. The discussion also further explores evolving strategies for patients with BCG-unresponsive disease, including promising therapeutic options amid the ongoing BCG shortage.
No reviews yet